Same protocol. No prescription.
SleepShift vs Somryst:
The honest comparison.
Somryst was the first FDA-cleared digital CBT-I program. After Pear Therapeutics' Chapter 11 in April 2023, Nox Health acquired Somryst at auction and now distributes it exclusively through employer health plans and health systems — not direct to consumers. SleepShift delivers the same 5-component CBT-I protocol direct-to-consumer, with no prescription, no waitlist, and a free first week.
Free
first week · then $29.99/mo
- Full 5-component CBT-I protocol
- Free first week, then $29.99/mo
- No prescription required
- Start immediately
- Reviewed by Dr. Candice Seti, Psy.D.
- Cancel anytime · 14-day money-back guarantee
B2B only
via employer plans (Nox Health, since 2023)
- Full 5-component CBT-I protocol (9-week)
- No direct-to-consumer purchase path
- Requires doctor prescription
- Employer enrollment + Rx wait
- FDA-cleared (retained by Nox Health)
- HSA/FSA eligible (when employer-provided)
- Was $899 direct-to-consumer under Pear (2020–2023) · no current consumer price
Feature-by-feature comparison
| Feature | SleepShift | Somryst |
|---|---|---|
| Direct-to-consumer access | Yes — start today | No — B2B only since June 2023 |
| Price | Free first week, then $29.99/mo | Not sold direct to consumers (was $899 under Pear, 2020–2023) |
| Prescription required | No | Yes — physician required |
| Wait time | Start today | Employer enrollment + Rx wait |
| CBT-I protocol | Full 5-component | Full 5-component (9-week) |
| FDA status | Not FDA-cleared (wellness) | FDA-cleared (Rx DTx) |
| Try before full price | Free first week | No — full price upfront |
| Clinical reviewer / operator | Dr. Candice Seti, Psy.D. | Nox Health (acquired from Pear, 2023) |
| Cancellation | Cancel anytime | Through employer plan |
Somryst pricing and requirements based on publicly available product information. Prices and availability subject to change.
The honest take
What Somryst's FDA clearance actually means
Somryst's FDA clearance validates one important thing: a digital program can deliver CBT-I effectively.The FDA reviewed Somryst's clinical evidence and cleared it as a product — consistent with what the peer-reviewed CBT-I literature has shown since the 1980s.
The FDA clearance is for Somryst as a specific prescription medical device — not for CBT-I as a concept. CBT-I is a published clinical protocol. SleepShift uses the same published protocol, reviewed by Dr. Candice Seti, Psy.D., a Certified Insomnia Treatment Clinician.
Since Pear Therapeutics' Chapter 11 in 2023, Somryst is no longer sold direct to consumers — Nox Health distributes it through employer health plans only. If your employer offers Nox's sleep program and FDA clearance matters to you, that's a fit. If you want immediate direct access to the same evidence-based protocol, SleepShift is the right choice.
Common questions
Is SleepShift as effective as Somryst?
Both programs deliver the same five CBT-I components — sleep restriction, stimulus control, cognitive restructuring, relaxation, and sleep education. The 70–80% improvement figure comes from published trials of the CBT-I method itself, not from either product. SleepShift has not run its own clinical trial and does not claim equivalence to an FDA-cleared medical device. Its protocol is reviewed by Dr. Candice Seti, Psy.D., a Certified Insomnia Treatment Clinician, for clinical fidelity.
Can I just buy Somryst directly?
Not anymore. After Pear Therapeutics filed for Chapter 11 in April 2023, Nox Health acquired Somryst at auction in June 2023 and now distributes it exclusively through employers, health plans, and health systems. There is no direct-to-consumer purchase path — you can only access Somryst if your employer or health plan offers it. SleepShift is direct-to-consumer.
Do I need a doctor to use SleepShift?
No. SleepShift requires no referral, prescription, or doctor visit to start. It is a wellness program, not a medical assessment, so it does not screen you for other conditions — the sleep-restriction component is used cautiously with untreated sleep apnea, untreated bipolar disorder, and some seizure disorders, so talk to your doctor first if any of those apply to you. For the majority of adults with primary chronic insomnia, you can start immediately.
What is Somryst's FDA clearance?
Somryst received FDA clearance as a prescription digital therapeutic (DTx) for adults 22+ with chronic insomnia. The clearance is retained by Nox Health, the current owner. FDA clearance covers Somryst as a product. The protocol both programs deliver — CBT-I — is backed by decades of published trials. Somryst itself remains prescription-only, distributed through provider and employer-sponsored channels. SleepShift uses the same published CBT-I protocol as a wellness program.
What if I want an FDA-cleared product?
If FDA clearance is your requirement, check whether your employer's benefits include Nox Health's sleep program (which now includes Somryst). If your employer doesn't offer it — or you want immediate access without going through a benefits administrator — SleepShift delivers the same five-component CBT-I protocol direct to you.
Free first week
The same protocol.
Free first week.
No prescription. No employer plan required. Start with the free 3-minute assessment — see your insomnia profile and projected CBT-I plan before committing to anything.
$0 first week · then $29.99/mo · cancel anytime · Reviewed by Dr. Candice Seti, Psy.D.
SleepShift is a structured wellness program and is not a medical device or FDA-cleared product. This comparison is provided for informational purposes. Product information for Somryst sourced from publicly available materials and may change. SleepShift does not claim equivalence to FDA-cleared medical devices.